Related Experiment Video
Updated: Jun 13, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular Disease Patterns, Mortality, and Hospitalization Trends in Adults Over 18: Insights From the
Okelue E Okobi1,2,3, Enyioma Nwogwugwu4, Cosmas O Ihezie5
1Family Medicine, Larkin Community Hospital Palm Springs Campus, Miami, USA.
Insights
Cardiovascular disease medication use is rising, but mortality rates for heart attack and stroke remain high. Significant disparities exist, highlighting the need for targeted interventions and improved health equity.
Area of Science:
- Public Health
- Epidemiology
- Cardiovascular Medicine
Background:
- Cardiovascular diseases (CVDs) are the leading global cause of death, with prevalence increasing despite medical advancements.
- Understanding trends in CVD risk factors and treatment is crucial for effective public health strategies.
- This study analyzes CVD trends using the Behavioral Risk Factor Surveillance System (BRFSS) data.
Purpose of the Study:
- To analyze trends in cardiovascular disease (CVD) prevalence, medication use, and mortality from 2019 to 2021.
- To identify demographic disparities in CVD outcomes.
- To inform public health interventions for CVD risk reduction.
Main Methods:
- Utilized Behavioral Risk Factor Surveillance System (BRFSS) data from 2019-2021.
- Included adults over 18 with conditions like high cholesterol, hypertension, coronary heart disease, stroke, and heart failure.
- Employed age-adjusted prevalence, mortality rates, and hospitalization data for analysis.
Main Results:
- Age-adjusted prevalence of medication use for high cholesterol and blood pressure significantly increased (p<0.05).
- Coronary heart disease and stroke mortality rates rose significantly (p<0.05), with higher rates in males and Black, non-Hispanic individuals.
- Heart failure hospitalization rates fluctuated, initially decreasing in 2020 due to the pandemic before rising in 2021.
Conclusions:
- Despite increased medication use for cholesterol and blood pressure, CVD mortality persists.
- Significant gender and racial disparities in CVD medication use and mortality necessitate targeted interventions.
- Addressing social determinants of health and improving medication adherence are vital for reducing CVD burden and enhancing health equity.
Abstract:
Background Cardiovascular diseases (CVDs), including coronary artery disease, heart attacks, strokes, and hypertension, are the leading cause of global morbidity and mortality. Despite advancements in diagnostic techniques, treatment protocols, and public health initiatives, the prevalence of CVD continues to rise. Hence, understanding trends of predisposing factors for CVD and current treatment modalities such as medication use and frequency of hospitalization is essential for developing effective interventions and improving public health strategies. This study leverages Behavioral Risk Factor Surveillance System (BRFSS) data to analyze these trends among adults older than 18 years. Methods Data were sourced from the BRFSS database, analyzing CVD patterns from 2019 to 2021. The study included adults with high cholesterol or blood pressure, coronary heart disease, stroke, and heart failure. Data analysis utilized age-adjusted prevalence, mortality, and hospitalization rates. Results The analysis of the BRFSS data revealed several key trends in CVD patterns from 2019 to 2021. There was a statistically significant increase (p<0.05) in the age-adjusted prevalence of adults taking medication for high cholesterol, rising from 28.9% to 31%, and for controlling high blood pressure, increasing from 57.7% to 60.4%. From 2019 to 2021, coronary heart disease mortality increased from 360,900 to 382,820, while stroke deaths rose from 150,005 to 162,890. Trends show rising mortality for both conditions despite missing data for some years. Mortality rates for coronary heart disease and stroke also rose and were statistically significant (p<0.05), with coronary heart disease mortality increasing from 88 to 92.8 cases per 100,000, and stroke mortality from 37 to 41.1 cases per 100,000. Hospitalization rates for heart failure among Medicare beneficiaries aged 65 and older initially decreased in 2020, likely due to the COVID-19 pandemic impacting hospital admissions, but rose again in 2021 as healthcare-seeking behaviors normalized. Significant gender and racial disparities were observed, with higher mortality rates among males (127.4 per 100,000) and Black, non-Hispanic individuals (110.5 per 100,000). Conclusions This study highlights the increasing medication use for cholesterol and blood pressure among adults older than 18 years, yet mortality rates for coronary heart disease and stroke persist. Significant gender and racial disparities in medication use and mortality rates were observed. These findings underscore the need for targeted public health intervention towards improving medication adherence and addressing social determinants of health, to reduce CVD burden and enhance health equity across diverse populations.
More Related Videos
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

